# The Safety and Immunogenicity of a Potential HIV Vaccine

> **NCT01966900** · PHASE1 · COMPLETED · sponsor: **Imperial College London** · enrollment: 14 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** CN54gp140 mixed with GLA-AF

## Key facts

- **NCT ID:** NCT01966900
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-11-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01966900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01966900, "The Safety and Immunogenicity of a Potential HIV Vaccine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01966900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*